Tempo Financial Statements From 2010 to 2024

TSPC Stock  IDR 2,520  20.00  0.79%   
Tempo Scan financial statements provide useful quarterly and yearly information to potential Tempo Scan Pacific investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Tempo Scan financial statements helps investors assess Tempo Scan's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Tempo Scan's valuation are summarized below:
Tempo Scan Pacific does not presently have any fundamental trend indicators for analysis.
Check Tempo Scan financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tempo Scan's main balance sheet or income statement drivers, such as , as well as many indicators such as . Tempo financial statements analysis is a perfect complement when working with Tempo Scan Valuation or Volatility modules.
  
This module can also supplement various Tempo Scan Technical models . Check out the analysis of Tempo Scan Correlation against competitors.

Tempo Scan Pacific Company Return On Equity Analysis

Tempo Scan's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Tempo Scan Return On Equity

    
  0.12  
Most of Tempo Scan's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tempo Scan Pacific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Tempo Scan Pacific has a Return On Equity of 0.1236. This is 100.52% lower than that of the Pharmaceuticals sector and 94.25% lower than that of the Health Care industry. The return on equity for all Indonesia stocks is 139.87% lower than that of the firm.

Tempo Scan Pacific Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tempo Scan's current stock value. Our valuation model uses many indicators to compare Tempo Scan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tempo Scan competition to find correlations between indicators driving Tempo Scan's intrinsic value. More Info.
Tempo Scan Pacific is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about  0.49  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Tempo Scan Pacific is roughly  2.05 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tempo Scan's earnings, one of the primary drivers of an investment's value.

About Tempo Scan Financial Statements

Tempo Scan investors utilize fundamental indicators, such as revenue or net income, to predict how Tempo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. PT Tempo Scan Pacific Tbk is a subsidiary of PT Bogamulia Nagadi. Tempo Scan operates under Drug Manufacturers - Major classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 5610 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Tempo Stock

Tempo Scan financial ratios help investors to determine whether Tempo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tempo with respect to the benefits of owning Tempo Scan security.